Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2020-02-14 2:44 pm Sale | 13G | X4 PHARMACEUTICALS INC XFOR | EcoR1 Capital LLC | 1,015,400 6.1% | -184,600 (-15.38%) | View |
2020-02-14 2:42 pm Sale | 13G | EXICURE INC XCUR | EcoR1 Capital LLC | 3,544,186 4.1% | -2,401,039 (-40.39%) | View |
2020-02-14 2:40 pm Sale | 13G | SURFACE ONCOLOGY INC SURF | EcoR1 Capital LLC | 1,301,713 4.7% | -959,615 (-42.44%) | View |
2020-02-14 2:38 pm Sale | 13G | PREVAIL THERAPEUTICS INC PRVL | EcoR1 Capital LLC | 2,248,306 6.6% | -144,250 (-6.03%) | View |
2020-02-14 2:36 pm Sale | 13G | MORPHIC HLDG INC MORF | EcoR1 Capital LLC | 2,154,845 7.1% | -84,859 (-3.79%) | View |
2020-02-14 2:34 pm Purchase | 13G | MERUS N V COM MRUS | EcoR1 Capital LLC | 1,718,200 6% | 1,718,200 (New Position) | View |
2020-02-14 2:31 pm Sale | 13G | KURA ONCOLOGY INC KURA | EcoR1 Capital LLC | 4,241,953 9.4% | -1,034,800 (-19.61%) | View |
2020-02-14 2:29 pm Sale | 13G | EIGER BIOPHARMACEUTICALS INC C EIGR | EcoR1 Capital LLC | 449,338 1.8% | -1,146,305 (-71.84%) | View |
2020-02-14 2:27 pm Purchase | 13G | DICERNA PHARMACEUTICALS INC CO DRNA | EcoR1 Capital LLC | 3,627,597 5.3% | 311,190 (+9.38%) | View |
2020-02-14 2:20 pm Unchanged | 13G | CHIASMA INC CHMA | EcoR1 Capital LLC | 3,043,827 7.2% | 0 (Unchanged) | View |
2020-02-14 2:17 pm Sale | 13G | ATRECA INC BCEL | EcoR1 Capital LLC | 1,481,411 6.7% | -5,568 (-0.37%) | View |
2020-02-14 2:12 pm Purchase | 13G | ANAPTYSBIO INC ANAB | EcoR1 Capital LLC | 1,966,100 7.2% | 245,600 (+14.27%) | View |
2020-02-14 2:09 pm Purchase | 13G | ACLARIS THERAPEUTICS INC ACRS | EcoR1 Capital LLC | 2,087,312 5% | 2,087,312 (New Position) | View |
2020-02-14 2:05 pm Sale | 13G | SCHOLAR ROCK HLDG CORP SRRK | EcoR1 Capital LLC | 0 0% | -1,474,228 (Position Closed) | View |
2020-02-14 2:03 pm Sale | 13G | ONCONOVA THERAPEUTICS INC ONTX | EcoR1 Capital LLC | 0 0% | -423,441 (Position Closed) | View |
2020-02-14 2:00 pm Sale | 13G | KEZAR LIFE SCIENCES INC KZR | EcoR1 Capital LLC | 0 0% | -1,060,018 (Position Closed) | View |
2020-02-14 1:58 pm Sale | 13G | ZAFGEN INC ZFGN | EcoR1 Capital LLC | 0 0% | -3,141,323 (Position Closed) | View |
2020-02-14 1:55 pm Sale | 13G | SOLID BIOSCIENCES INC SLDB | EcoR1 Capital LLC | 0 0% | -3,102,238 (Position Closed) | View |
2020-02-14 1:53 pm Sale | 13G | CURIS INC CRIS | EcoR1 Capital LLC | 0 0% | -2,982,208 (Position Closed) | View |
2020-02-14 1:50 pm Sale | 13G | ARBUTUS BIOPHARMA CORP ABUS | EcoR1 Capital LLC | 0 0% | -3,281,502 (Position Closed) | View |